Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

Trump’s pick for NIH director clears committee, heads to full Senate vote

by March 13, 2025
March 13, 2025

The Senate Committee on Health, Education, Labor and Pensions (HELP) voted Thursday morning to advance President Donald Trump’s pick to head the National Institutes of Health, Dr. Jay Bhattacharya. 

The vote was strictly along party lines, 12 votes in favor and 11 against, but with the committee having one extra Republican member in the majority, Bhattacharya sailed to the finish line with only GOP support. Bhattacharya now heads to the full Senate for an impending confirmation vote that will be the last hurdle before he becomes the next director of the NIH.   

Sen. Bernie Sanders, I-Vt., expressed concern Thursday, saying he feared Bhattacharya would not do enough to help lower the cost of prescription drugs. Sanders and other Democrats have also expressed concern over how Bhattacharya will approach medical research at the NIH, especially considering Trump just imposed a cap on facilities and administration costs associated with NIH research grants. 

   

A physician, Stanford professor of medicine and senior fellow at the university’s Institute for Economic Policy Research, Bhattacharya was a leading voice during the COVID-19 pandemic against lockdown measures and vaccine mandates. 

Bhattacharya was probed by the Senate HELP Committee roughly a week ago over various issues related to his potential role as NIH director; however, much of the hearing he was forced to defend the president’s decision to put a 15% cap on indirect research costs dispersed by the NIH.

Bhattacharya would not explicitly say he disagreed with the cuts, or that, if confirmed, he would step in to stop them. Rather, he said he would ‘follow the law,’ while also investigating the impact of the cuts and ensuring every NIH researcher doing work that advances the health outcomes of Americans has the resources necessary.

In addition to addressing questions about the Trump cuts, Bhattacharya also laid out what he called a new, decentralized vision for future research at NIH that he said will be aimed at embracing dissenting ideas and transparency, while focusing on research topics that have the best chance at directly benefiting health outcomes of Americans. Bhattacharya added that he wants to rid the agency’s research portfolio of other ‘frivolous’ efforts that he says do little to directly benefit health outcomes.

‘I think fundamentally what matters is: Do scientists have an idea that advances the scientific field they’re in?’ Bhattacharya said last week during his confirmation testimony. ‘Do they have an idea that ends up addressing the health needs of Americans?’

Bhattacharya was notably a co-author of the Great Barrington Declaration, a document published in October 2020 by a group of scientists advocating for an alternative approach to handling the COVID-19 pandemic. It argued largely against widespread lockdowns and promoted the efficacy of natural immunity to the virus for low-risk individuals, suggesting the vaccine may not be the best course of action for everyone.

Prior to his confirmation hearings, Bhattacharya, alongside several other scientists, including Trump’s pick to head the Food and Drug Administration, Dr. Marty Makary, launched a new research journal focused on spurring scientific discourse and combating ‘gatekeeping’ in the medical research community. The journal, titled the Journal of the Academy of Public Health (JAPH), aims to spur scientific discourse by publishing peer reviews of prominent studies from other journals that do not make their peer reviews publicly available. 

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Dr. Marty Makary advances out of key committee in bid for FDA confirmation
next post
‘This is no drill’: China’s dominance over US shipbuilding sparks bipartisan effort

You may also like

Harris entertains Supreme Court-packing question during town hall,...

October 24, 2024

AOC, ‘baby girl’ Marjorie Taylor Greene trade barbs...

May 17, 2024

Michelle Obama Says Americans Weren’t Ready For Her...

November 18, 2022

EXCLUSIVE – ANDREW WEISSMANN PART XII: Weissmann Placed...

October 25, 2022

Ramaswamy changes tune from previous comments on Trump...

August 21, 2023

Indian Government Blames Public for Getting Vaccines Despite...

November 30, 2022

Hohmann: Mockingbird Media Dishes Up a Load of...

September 24, 2022

Resident Shoots and Kills 1 Suspected Intruder and...

November 28, 2022

BREAKING: Elections Clerk Says Uncounted Maricopa County Ballots...

November 13, 2022

Biden’s former spokesman slams Trump and GOP ‘colluding...

March 21, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Leadership Development: Unlocking the Inner Leader

      May 24, 2025
    • Satellite images reveal North Korea’s mangled naval destroyer after failed launch

      May 24, 2025
    • Trump administration plans to overhaul National Security Council, weeks after Waltz’s departure

      May 24, 2025
    • 3 Stocks to Watch While Everyone’s Staring at NVIDIA

      May 24, 2025
    • Automate Your Scans with Ease! Sample Scan Library + Scheduled Scans Walkthrough

      May 23, 2025
    • My Durable Advantage as an Investor is My Experience: Here are Seven Examples

      May 23, 2025

    Categories

    • Business (8,037)
    • Investing (1,986)
    • Politics (15,362)
    • Stocks (3,105)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved